Company Description
Kestra Medical Technologies is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest.
The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patient’s heart to normal rhythm.
As of January 31, 2025, our system is actively being prescribed by more than 550 hospitals across the US, and has been worn by over 17,000 patients since it was fully commercially launched.
| Country | United States |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 300 |
| CEO | Brian Webster |
Contact Details
Address: 3933 Lake Washington Blvd NE, Suite 200 Kirkland, WA 98033 United States | |
| Phone | (425) 279-8002 |
| Website | kestramedical.com |
Stock Details
| Ticker Symbol | KMTS |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| CIK Code | 0001877184 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Brian Webster | President, Chief Executive Officer, and Director |
| Vaseem Mahboob | Chief Financial Officer |
| Traci S. Umberger | General Counsel, Chief Administrative Officer, and Director |
| Phillip D. Foshee, Jr. | Senior Vice President of Research & Development |
| Debra Schotz | Senior Vice President of Marketing |
| Jeffrey Laub | Senior Vice President of Supply Chain Operations |
| Jeffrey Schwartz | Director, Chairman of the Board of Directors |
| Raymond W. Cohen | Director |
| Christopher Gordon | Director |
| Mary Kay Ladone | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 10, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Feb 4, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jan 17, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Dec 11, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Nov 23, 2021 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Aug 25, 2021 | DRS | [Cover] Draft Registration Statement |